PROC
Procaps Group SAKey Statistics
About Procaps Group SA
Procaps Group SA (PROC) is a leading pharmaceutical and healthcare company based in Latin America, specializing in the production of high-quality pharmaceutical products and nutraceuticals. With a strong focus on innovation and research, Procaps leverages advanced technologies to create value-added solutions in the pharmaceutical industry, positioning itself as a key player in the growing healthcare market. The company operates a robust manufacturing infrastructure, complemented by strategic partnerships that enhance its distribution capabilities across key regional markets. Additionally, Procaps is dedicated to sustainability and social responsibility, aligning its business practices with global health trends and increasing demand for health and wellness products.
Fundamentals
| Revenue (TTM) | $414.10M |
| Gross Profit (TTM) | $227.91M |
| EBITDA | $57.06M |
| Operating Margin | 11.10% |
| Return on Equity | 37.40% |
| Return on Assets | 6.28% |
| Revenue/Share (TTM) | $4.10 |
| Book Value | $0.39 |
| Price-to-Book | 64.34 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 6.76 |
| EV/EBITDA | 22.67 |
| Quarterly Earnings Growth (YoY) | -63.70% |
| Quarterly Revenue Growth (YoY) | 7.30% |
| Shares Outstanding | $112.82M |
| Float | $17.15M |
| % Insiders | 83.03% |
| % Institutions | 2.92% |
Historical Volatility
Volatility is currently contracting